The DOI matches its Crossref record; 216 of the 216 references it cites were found in a registry or an index.
Diabetic Cardiomyopathy: Evidence, Mechanisms, and Therapeutic Implications
Abstract
The presence of a diabetic cardiomyopathy, independent of hypertension and coronary artery disease, is still controversial. This systematic review seeks to evaluate the evidence for the existence of this condition, to clarify the possible mechanisms responsible, and to consider possible therapeutic implications. The existence of a diabetic cardiomyopathy is supported by epidemiological findings showing the association of diabetes with heart failure; clinical studies confirming the association of diabetes with left ventricular dysfunction independent of hypertension, coronary artery disease, and other heart disease; and experimental evidence of myocardial structural and functional changes. The most important mechanisms of diabetic cardiomyopathy are metabolic disturbances (depletion of glucose transporter 4, increased free fatty acids, carnitine deficiency, changes in calcium homeostasis), myocardial fibrosis (association with increases in angiotensin II, IGF-I, and inflammatory cytokines), small vessel disease (microangiopathy, impaired coronary flow reserve, and endothelial dysfunction), cardiac autonomic neuropathy (denervation and alterations in myocardial catecholamine levels), and insulin resistance (hyperinsulinemia and reduced insulin sensitivity). This review presents evidence that diabetes is associated with a cardiomyopathy, independent of comorbid conditions, and that metabolic disturbances, myocardial fibrosis, small vessel disease, cardiac autonomic neuropathy, and insulin resistance may all contribute to the development of diabetic heart disease.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
(2000) · New England Journal of Medicine · doi:10.1056/nejm200001203420301 · Cited by 8,663
Role of diabetes in congestive heart failure: The Framingham study
Kannel, W. B., Hjortland, M., & Castelli, W. P. (1974) · The American Journal of Cardiology · doi:10.1016/0002-9149(74)90089-7 · Cited by 2,090
Weber, K. T., & Brilla, C. G. (1991) · Circulation · doi:10.1161/01.cir.83.6.1849 · Cited by 2,027
New type of cardiomyopathy associated with diabetic glomerulosclerosis
Rubler, S., Dlugash, J., Yuceoglu, Y. Z., Kumral, T., Branwood, A. W., & Grishman, A. (1972) · The American Journal of Cardiology · doi:10.1016/0002-9149(72)90595-4 · Cited by 1,837
Sohn, D.-W., Chai, I.-H., Lee, D.-J., Kim, H.-C., Kim, H.-S., Oh, B.-H., Lee, M.-M., Park, Y.-B., Choi, Y.-S., Seo, J.-D., et al. (1997) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(97)88335-0 · Cited by 1,557
Diabetes, Hypertension, and Cardiovascular Disease: An Update
Sowers, J. R., Epstein, M., & Frohlich, E. D. (2001) · Hypertension · doi:10.1161/01.hyp.37.4.1053 · Cited by 1,332
Protein kinase C activation and the development of diabetic complications.
Koya, D., & King, G. L. (1998) · Diabetes · doi:10.2337/diabetes.47.6.859 · Cited by 1,330
Hypertension and Antihypertensive Therapy as Risk Factors for Type 2 Diabetes Mellitus
Gress, T. W., Nieto, F. J., Shahar, E., Wofford, M. R., & Brancati, F. L. (2000) · New England Journal of Medicine · doi:10.1056/nejm200003303421301 · Cited by 1,202
Bucala, R., Tracey, K. J., & Cerami, A. (1991) · Journal of Clinical Investigation · doi:10.1172/jci115014 · Cited by 1,165
Impaired endothelium-dependent vasodilation in patients with insulin-dependent diabetes mellitus.
Johnstone, M. T., Creager, S. J., Scales, K. M., Cusco, J. A., Lee, B. K., & Creager, M. A. (1993) · Circulation · doi:10.1161/01.cir.88.6.2510 · Cited by 1,124
Cited by
Mechanisms of Diabetic Complications
Forbes, J. M., & Cooper, M. E. (2013) · Physiological Reviews · doi:10.1152/physrev.00045.2011 · Cited by 2,890
Diabetic Cardiomyopathy Revisited
Boudina, S., & Abel, E. D. (2007) · Circulation · doi:10.1161/circulationaha.106.679597 · Cited by 1,543
Low Wang, C. C., Hess, C. N., Hiatt, W. R., & Goldfine, A. B. (2016) · Circulation · doi:10.1161/circulationaha.116.022194 · Cited by 1,155
Insulin resistance and hyperinsulinaemia in diabetic cardiomyopathy
Jia, G., DeMarco, V. G., & Sowers, J. R. (2016) · Nature Reviews Endocrinology · doi:10.1038/nrendo.2015.216 · Cited by 949
Diabetic cardiomyopathy: a hyperglycaemia- and insulin-resistance-induced heart disease
Jia, G., Whaley-Connell, A., & Sowers, J. R. (2018) · Diabetologia · doi:10.1007/s00125-017-4390-4 · Cited by 868
Epidemiology of Sudden Cardiac Death: Clinical and Research Implications
Chugh, S. S., Reinier, K., Teodorescu, C., Evanado, A., Kehr, E., Al Samara, M., Mariani, R., Gunson, K., & Jui, J. (2008) · Progress in Cardiovascular Diseases · doi:10.1016/j.pcad.2008.06.003 · Cited by 729
van Heerebeek, L., Hamdani, N., Handoko, M. L., Falcao-Pires, I., Musters, R. J., Kupreishvili, K., Ijsselmuiden, A. J. J., Schalkwijk, C. G., Bronzwaer, J. G. F., Diamant, M., et al. (2008) · Circulation · doi:10.1161/circulationaha.107.728550 · Cited by 723
Diabetic Cardiomyopathy: The Search for a Unifying Hypothesis
Poornima, I. G., Parikh, P., & Shannon, R. P. (2006) · Circulation Research · doi:10.1161/01.res.0000207406.94146.c2 · Cited by 571
Clinical diabetic cardiomyopathy: a two-faced disease with restrictive and dilated phenotypes
Seferović, P. M., & Paulus, W. J. (2015) · European Heart Journal · doi:10.1093/eurheartj/ehv134 · Cited by 552
Huynh, K., Bernardo, B. C., McMullen, J. R., & Ritchie, R. H. (2014) · Pharmacology & Therapeutics · doi:10.1016/j.pharmthera.2014.01.003 · Cited by 553
Metabolic Mechanisms in Heart Failure
Ashrafian, H., Frenneaux, M. P., & Opie, L. H. (2007) · Circulation · doi:10.1161/circulationaha.107.702795 · Cited by 521
Diabetic Microvascular Disease: An Endocrine Society Scientific Statement
Barrett, E. J., Liu, Z., Khamaisi, M., King, G. L., Klein, R., Klein, B. E. K., Hughes, T. M., Craft, S., Freedman, B. I., Bowden, D. W., et al. (2017) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2017-01922 · Cited by 515
Role of changes in cardiac metabolism in development of diabetic cardiomyopathy
An, D., & Rodrigues, B. (2006) · American Journal of Physiology-Heart and Circulatory Physiology · doi:10.1152/ajpheart.00278.2006 · Cited by 446
Macrovascular Complications of Type 2 Diabetes Mellitus
Viigimaa, M., Sachinidis, A., Toumpourleka, M., Koutsampasopoulos, K., Alliksoo, S., & Titma, T. (2020) · Current Vascular Pharmacology · doi:10.2174/1570161117666190405165151 · Cited by 387
Marwick, T. H., Hordern, M. D., Miller, T., Chyun, D. A., Bertoni, A. G., Blumenthal, R. S., Philippides, G., & Rocchini, A. (2009) · Circulation · doi:10.1161/circulationaha.109.192521 · Cited by 370
Self-citationInsulin-Resistant Cardiomyopathy
Witteles, R. M., & Fowler, M. B. (2008) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.10.021 · Cited by 351
NF-κβ: A Potential Target in the Management of Vascular Complications of Diabetes
Suryavanshi, S. V., & Kulkarni, Y. A. (2017) · Frontiers in Pharmacology · doi:10.3389/fphar.2017.00798 · Cited by 348
Vascular endothelial dysfunction, a major mediator in diabetic cardiomyopathy
Knapp, M., Tu, X., & Wu, R. (2019) · Acta Pharmacologica Sinica · doi:10.1038/s41401-018-0042-6 · Cited by 328
Tranilast: A review of its therapeutic applications
Darakhshan, S., & Pour, A. B. (2015) · Pharmacological Research · doi:10.1016/j.phrs.2014.10.009 · Cited by 322
Endothelial glycocalyx dysfunction in disease: albuminuria and increased microvascular permeability
Salmon, A. H., & Satchell, S. C. (2012) · The Journal of Pathology · doi:10.1002/path.3964 · Cited by 315
Vlagopoulos, P. T., Tighiouart, H., Weiner, D. E., Griffith, J., Pettitt, D., Salem, D. N., Levey, A. S., & Sarnak, M. J. (2005) · Journal of the American Society of Nephrology · doi:10.1681/asn.2005030226 · Cited by 314
MicroRNAs in cardiovascular disease: from pathogenesis to prevention and treatment
Quiat, D., & Olson, E. N. (2013) · Journal of Clinical Investigation · doi:10.1172/jci62876 · Cited by 300
Donaghue, K. C., Marcovecchio, M. L., Wadwa, R. P., Chew, E. Y., Wong, T. Y., Calliari, L. E., Zabeen, B., Salem, M. A., & Craig, M. E. (2018) · Pediatric Diabetes · doi:10.1111/pedi.12742 · Cited by 298
Recent advances in understanding the biochemical and molecular mechanism of diabetic retinopathy
Wan, T.-T., Li, X.-F., Sun, Y.-M., Li, Y.-B., & Su, Y. (2015) · Biomedicine & Pharmacotherapy · doi:10.1016/j.biopha.2015.08.002 · Cited by 291
Westermann, D., Rutschow, S., Jäger, S., Linderer, A., Anker, S., Riad, A., Unger, T., Schultheiss, H.-P., Pauschinger, M., & Tschöpe, C. (2007) · Diabetes · doi:10.2337/db06-1163 · Cited by 273
Paolillo, S., Marsico, F., Prastaro, M., Renga, F., Esposito, L., De Martino, F., Di Napoli, P., Esposito, I., Ambrosio, A., Ianniruberto, M., et al. (2019) · Heart Failure Clinics · doi:10.1016/j.hfc.2019.02.003 · Cited by 257
Gender-specific care of the patient with diabetes: review and recommendations
Legato, M. J., Gelzer, A., Goland, R., Ebner, S. A., Rajan, S., Villagra, V., & Kosowski, M. (2006) · Gender Medicine · doi:10.1016/s1550-8579(06)80202-0 · Cited by 225
Laustsen, P. G., Russell, S. J., Cui, L., Entingh-Pearsall, A., Holzenberger, M., Liao, R., & Kahn, C. R. (2007) · Molecular and Cellular Biology · doi:10.1128/mcb.01110-06 · Cited by 173
“Most of the cardiac morbidity and mortality in diabetic patients relates to atherosclerotic disease, but there may also be an increased risk of heart failure independent of vascular pathology associated with diabetes (15, 40).”
BackgroundZhao, Y., Zhang, L., Qiao, Y., Zhou, X., Wu, G., Wang, L., Peng, Y., Dong, X., Huang, H., Si, L., et al. (2013) · PLoS ONE · doi:10.1371/journal.pone.0075927 · Cited by 138
Sacre, J. W., Franjic, B., Jellis, C. L., Jenkins, C., Coombes, J. S., & Marwick, T. H. (2010) · JACC: Cardiovascular Imaging · doi:10.1016/j.jcmg.2010.09.014 · Cited by 123
Self-citationDiabetes and Cardiovascular Disease: an Update
Almourani, R., Chinnakotla, B., Patel, R., Kurukulasuriya, L. R., & Sowers, J. (2019) · Current Diabetes Reports · doi:10.1007/s11892-019-1239-x · Cited by 114
Insulin Resistance and Risk of Incident Heart Failure: Cardiovascular Health Study
Banerjee, D., Biggs, M. L., Mercer, L., Mukamal, K., Kaplan, R., Barzilay, J., Kuller, L., Kizer, J. R., Djousse, L., Tracy, R., et al. (2013) · Circulation: Heart Failure · doi:10.1161/circheartfailure.112.000022 · Cited by 105
Cai, L. (2006) · Free Radical Biology and Medicine · doi:10.1016/j.freeradbiomed.2006.06.007 · Cited by 99
Association Between Cardiovascular Autonomic Neuropathy and Left Ventricular Dysfunction
Pop-Busui, R., Cleary, P. A., Braffett, B. H., Martin, C. L., Herman, W. H., Low, P. A., Lima, J. A. C., & Bluemke, D. A. (2013) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2012.10.028 · Cited by 88
Scott, J. A., Coombes, J. S., Prins, J. B., Leano, R. L., Marwick, T. H., & Sharman, J. E. (2008) · American Journal of Hypertension · doi:10.1038/ajh.2008.166 · Cited by 82
Van den Bergh, A., Flameng, W., & Herijgers, P. (2006) · European Journal of Heart Failure · doi:10.1016/j.ejheart.2006.03.001 · Cited by 68
Marra, A. M., Improda, N., Capalbo, D., Salzano, A., Arcopinto, M., De Paulis, A., Alessio, M., Lenzi, A., Isidori, A. M., Cittadini, A., et al. (2015) · The Journal of Clinical Endocrinology & Metabolism · doi:10.1210/jc.2014-1805 · Cited by 67
Tikellis, C., Pickering, R., Tsorotes, D., Du, X.-J., Kiriazis, H., Nguyen-Huu, T.-P., Head, G. A., Cooper, M. E., & Thomas, M. C. (2012) · Clinical Science · doi:10.1042/cs20110668 · Cited by 57
Glucose variability aggravates cardiac fibrosis by altering Akt signalling path
Ying, C., Liu, T., Ling, H., Cheng, M., Zhou, X., Wang, S., Mao, Y., Chen, L., Zhang, R., & Li, W. (2017) · Diabetes and Vascular Disease Research · doi:10.1177/1479164117698917 · Cited by 54
Cardiovascular autonomic neuropathy: A silent killer with long reach
Ang, L., Dillon, B., Mizokami-Stout, K., & Pop-Busui, R. (2020) · Autonomic Neuroscience · doi:10.1016/j.autneu.2020.102646 · Cited by 53
Improved diastolic function in type 2 diabetes after a six month liraglutide treatment
Saponaro, F., Sonaglioni, A., Rossi, A., Montefusco, L., Lombardo, M., Adda, G., & Arosio, M. (2016) · Diabetes Research and Clinical Practice · doi:10.1016/j.diabres.2016.04.046 · Cited by 41
Small animal cardiovascular MR imaging and spectroscopy
Bakermans, A. J., Abdurrachim, D., Moonen, R. P. M., Motaal, A. G., Prompers, J. J., Strijkers, G. J., Vandoorne, K., & Nicolay, K. (2015) · Progress in Nuclear Magnetic Resonance Spectroscopy · doi:10.1016/j.pnmrs.2015.03.001 · Cited by 35
Leung, V., Wroblewski, K., Schumm, L. P., Huisingh-Scheetz, M., & Huang, E. S. (2021) · The Journals of Gerontology: Series A · doi:10.1093/gerona/glab141 · Cited by 21
Huang, E. S., Liu, J. Y., Lipska, K. J., Grant, R. W., Laiteerapong, N., Moffet, H. H., Schumm, L. P., & Karter, A. J. (2023) · Journal of the American Geriatrics Society · doi:10.1111/jgs.18310 · Cited by 11
(2009) · PubMed Central
Metadata
- Authors
- Fang, Z. Y., Prins, J. B., & Marwick, T. H.
- Venue
- Endocrine Reviews
- Publisher
- The Endocrine Society
- Published
- 2004-08-01
- Volume
- 25
- Issue
- 4
- Pages
- 543-567
- ISSN
- 0163-769X (ISSN-L)
- 1945-7189
- OpenAlex
- W2054005523
- Cited by
- 912
- References
- 216
- FWCI
- 23.54
- Type
- journal article
- Language
- en
- Open access
- closed
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.